After Novo Holdings set the stage for a $16.5 billion buyout of contract manufacturing giant Catalent earlier this year, its ...
Danaher Corporation DHR is well poised for growth courtesy of strength across its end markets, strategic acquisitions and its focus on improving the product line and operational excellence. Image ...
Danaher Corporation is a leading player in the life science industry, with strong financial performance despite many spin-offs. The healthcare industry is facing challenges due to weak funding and ...
Danaher (DHR) closed at $248.46 in the latest trading session, marking a +0.27% move from the prior day. This move outpaced the S&P 500's daily loss of 0.28%. Elsewhere, the Dow saw a downswing of ...
Investors with significant funds have taken a bullish position in Danaher DHR, a development that retail traders should be aware of. This was brought to our attention today through our monitoring ...
Deep-pocketed investors have adopted a bearish approach towards Danaher DHR, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this ...
WASHINGTON, March 21, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the first quarter 2024 on Tuesday, April 23, 2024 ...
Danaher Corporation DHR is well poised for growth courtesy of strength across its end markets, strategic acquisitions and its focus on improving the product line and operational excellence. Image ...
Danaher (DHR) ended the recent trading session at $244.28, demonstrating a +0.98% swing from the preceding day's closing price. This move lagged the S&P 500's daily gain of 1.11%. Meanwhile, the ...